Contact Us

Irix

ReCheck

Get a second look at risks and detect applicant misrepresentation with data-driven hindsight.

You’ve accelerated your underwriting. Now use the same data-driven insight to bring your post-issue review up to speed, too.


Irix ReCheck empowers you spot more undisclosed high-risk conditions, limit denied or early-duration claims, and monitor producers or processes that may allow adverse selection to creep into your book.

Medical misrepresentation costs life insurance carriers in hassle, reputational harm, and early-duration claims. It also costs honest applicants by forcing carriers to raise premiums. But you can fight back with ReCheck.

ReCheck reorders a policyholder’s Prescription Data, Medical Data, or Risk Score three to six months into the contestability period. The Irix Rules Engine flags potential misrepresentation and clearly identifies new drugs or treatments that indicate unreported high-risk conditions. By spotting misrepresentation sooner, you’ll have time to take action—ranging from rate change to rescission—or simply allow suspicious policies to lapse or not to upsell.


What you may be missing without Recheck

Across all lines of business, ReCheck finds new decline rules in 7% of cases and new red drugs in 4% of cases. Customers who request agent monitoring identify about 2% of producers who have more than half their applications flagged. If one of them works for you, wouldn’t you like to know?

Without ReCheck, you lose out on critical post-issue advantages, including:

  • Vision into the mortality “time bombs” hiding in your book of business
  • The ability to precisely target cases for investigation
  • Protection from reputational harm and savings on legal expenses
  • Identification of policies that merit rate-class changes
  • Flagging of policies that should not be upsold or reinstated
  • An impartial review of producers’ performance

See more risks in retrospect with ReCheck

Hindsight really is 20/20 when you make smart use of data.

Carriers who use this powerful post-issue review tool get protection from adverse selection and report better public relations and fewer legal issues, more time for thorough investigations, kinder customer service, and the ability to take action on policies that may not claim within the contestable period.

Request a demo

Demo-Product Pages (#5)

Fight misrepresentation and catch mortality "time bombs" with data-driven post-issue review.

Run a test batch to see the misrepresentation that Irix ReCheck flags in your own book. Then capitalize on the the test by putting the results to work right away.